These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6777900)

  • 1. Complement (Clq), polyanions and platelet activation.
    Fiedel BA; Gewurz H
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):729-31. PubMed ID: 6777900
    [No Abstract]   [Full Text] [Related]  

  • 2. Clq inhibition of the interaction of collagen with human platelets.
    Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
    J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of platelet responses to collagen by Clq receptors.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1990 Jan; 144(1):221-5. PubMed ID: 2404063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1 and human platelets. II. Detection by immunological methods and role.
    Wautier JL; Tobelem GM; Peltier AP; Caen JP
    Immunology; 1976 Apr; 30(4):459-65. PubMed ID: 818006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1 and human platelets. Decrease in chronic lymphocyte leukemia. Effect of lymphocytes.
    Wautier JL; Tobelem GM; Peltier AP; Caen JP
    Pathol Biol (Paris); 1975 Dec; 23 suppl():33-6. PubMed ID: 817252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region of the Clq molecule involved in the interaction between platelets and subcomponent Clq of the first component of complement.
    Wautier JL; Reid KB; Legrand Y; Caen JP
    Mol Immunol; 1980 Nov; 17(11):1399-405. PubMed ID: 7464837
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of platelet collagen interactions by the C1s subcomponent of the first component of the first component of complement.
    Wautier JL; Legrand YJ; Fauvel F; Caen JP
    Thromb Res; 1981 Jan 1-15; 21(1-2):3-12. PubMed ID: 7015557
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aggregation and 3H-serotonin release from thrombocytes stimulated by serotonin in patients with migraine].
    Pukhal'skaia TG; Kolosova OA; Men'shikov MIu
    Biull Eksp Biol Med; 1998 Aug; 126(8):156-9. PubMed ID: 9777225
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human complement system in thrombin-mediated platelet function.
    Polley MJ; Nachman R
    J Exp Med; 1978 Jun; 147(6):1713-26. PubMed ID: 681879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of drugs that inhibit platelet release and aggregation.
    Shulman NR; Pollard HB; Tack-Goldman K; Buda E
    Trans Assoc Am Physicians; 1978; 91():104-17. PubMed ID: 38555
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets.
    Marney SR; Colley DG; Des Prez RM
    J Immunol; 1975 Feb; 114(2 Pt 1):696-703. PubMed ID: 804512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5HT2-receptors and serotonin release: their role in human platelet aggregation.
    Cerrito F; Lazzaro MP; Gaudio E; Arminio P; Aloisi G
    Life Sci; 1993; 53(3):209-15. PubMed ID: 8321084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human platelet activation by C3a and C3a des-arg.
    Polley MJ; Nachman RL
    J Exp Med; 1983 Aug; 158(2):603-15. PubMed ID: 6604123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function testing in the pony.
    Boudreaux MK; Wagner-Mann C; Purohit R; Hankes G; Spano J; Pablo L; Lee S; Conti J
    Lab Anim Sci; 1988 Aug; 38(4):448-51. PubMed ID: 3184855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CR3 receptor on platelets and its role in the prostaglandin metabolic pathway.
    Cosgrove LJ; d'Apice AJ; Haddad A; Pedersen J; McKenzie IF
    Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():453-60. PubMed ID: 2966106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosensitization and immune complexes in chronic idiopathic thrombocytopenic purpura.
    Clancy R; Trent R; Danis V; Davidson R
    Clin Exp Immunol; 1980 Jan; 39(1):170-5. PubMed ID: 6993065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A physiologic regulator of collagen-induced platelet aggregation: inhibition by Clq.
    Csákó G; Suba EA
    Thromb Haemost; 1981 Apr; 45(2):110-5. PubMed ID: 7256694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of interaction of different polyanions with the first (C1,C1) the second (C2) and the fourth (C4) component of complement. IV. Activation of C1 in serum by polyanions.
    Loos M; Bitter-Suermann D
    Immunology; 1976 Dec; 31(6):931-4. PubMed ID: 186401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet response to shear stress: changes in serotonin uptake, serotonin release, and ADP induced aggregation.
    Anderson GH; Hellums JD; Moake J; Alfrey CP
    Thromb Res; 1978 Dec; 13(6):1039-47. PubMed ID: 749261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.